Adrenolipoma pathophysiology

Jump to navigation Jump to search

Adrenolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenolipoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenolipoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenolipoma pathophysiology

CDC on Adrenolipoma pathophysiology

Adrenolipoma pathophysiology in the news

Blogs on Adrenolipoma pathophysiology

Directions to Hospitals Treating Adrenolipoma

Risk calculators and risk factors for Adrenolipoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

On gross pathology, central congested red to brown lesion, with thin cortical rim is a characteristic finding of adrenolipoma. On microscopic histopathological analysis, variable amounts of adipocytes and hematopietic cells are characteristic findings of adrenolipoma.

Pathogenesis

  • Myelolipomas are usually less than 4 cm in size occasionally measuring more than 10 cm in size.
  • Extra-adrenal sites for myelolipomas include the retroperitoneum, thorax, and pelvis.
  • Usually unilateral however they can also involve both adrenals.
  • One hypothesis suggests that stimuli, such as necrosis, inflammation, infection, or stress could cause adrenocortical cell metaplasia
  • If chronically present these stimulants lead to the development of neoplasms.This hypothesis is supported by the increased incidence of the lesion in the advanced years of life.
  • On gross pathologic examination, a cut section of a myelolipoma has a variegated appearance consisting of bright yellow areas of fat, dark red areas of hematopoietic myeloid tissue, and areas with intermixed red and yellow components.
  • On histopathologic examination, myelolipomas are predominantly composed of fatty areas with interspersed hematopoietic tissue components.
  • These fatty elements and hematopoietic areas may be clearly separated, or they are often intermixed.
  • Tissue analysis often reveals a variable amalgamation of myeloid and erythroid cells, megakaryocytes, and occasionally lymphocytes.
  • In an isolated adrenal myelolipoma, a peripheral rim of normal adrenal cortical tissue can be commonly identified distinctly from the mass.
  • Rarely the myelolipomas can contain osteoid tissue in addition to the myeloid tissue.

The hemorrhagic areas may be partly replaced by fibrotic tissue or may undergo calcification

Gross Pathology

Macroscopic examination demonstrates:[1]

Central congested red to brown lesion, with thin cortical rim. Large lesions may contain hemorrhage or infarction.

Microscopic Pathology

Histological examination demonstrates:[1]


References

Template:WH Template:WS